Currently, the expression of NE markers and Ki-67 index are mandatory requirements for the formulation of an EP-NEC diagnosis [1], whereas the morphological subtype is reported at the discretion of the pathologist. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.